English | Español
Patient Daily | Feb 22, 2026

Compass Pathways reports positive phase 3 results for psilocybin-based depression therapy
Patient Daily | Feb 22, 2026

Disc Medicine faces regulatory uncertainty after FDA rejects rare disease drug
Patient Daily | Feb 22, 2026

Biopharma faces rising costs as fetal bovine serum shortages tighten supplies
Patient Daily | Feb 22, 2026

Radiopharma industry boosts efforts to secure actinium‑225 amid growing demand
Patient Daily | Feb 22, 2026

Eli Lilly licenses CSL’s IL-6 antibody in $100M deal amid acquisition spree
Patient Daily | Feb 22, 2026

JAX-NYSCF partners with GSK to improve models for neurodegenerative disease research
Patient Daily | Feb 22, 2026

Musicians face increased risk of hearing problems regardless of genre
Patient Daily | Feb 22, 2026

Study links long-term air pollution exposure to increased Alzheimer’s risk

Trending
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures
+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'